RareSearch logo

BioLamina

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Bradford Kilback II profile

Bradford Kilback II

🇮🇹 Italy

9

    Reviewed:

  • - Biomarker Development
  • - 12 weeks October 2023 - January 2024
  • - Research Institution

Efficient and precise biomarker development.

The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.

Darryl Williamson profile

Darryl Williamson

🇪🇸 Spain

8.9

    Reviewed:

  • - Medical Writing
  • - 5 weeks October - November 2023
  • - Biotech Company

Top-quality medical writing, clear and precise documents.

The medical writing services provided were of top quality. The documents were clear, precise, and tailored to meet the specific requirements of our regulatory submissions. The team's expertise was evident throughout the process.

Bessie Cole profile

Bessie Cole

🇸🇦 Saudi Arabia

5.8

    Reviewed:

  • - Biostatistical Design
  • - 6 weeks February - March 2024
  • - Research Institution

Biostatistical analysis lacked depth, missed key insights.

The biostatistical analysis provided was not as thorough as we had hoped. Some key insights were missed, and we had to engage another provider to get the level of detail we needed. The team seemed overworked and under-resourced.

Karla Kutch profile

Karla Kutch

🇯🇵 Japan

8.8

    Reviewed:

  • - Biostatistical Design
  • - 4 weeks May - June 2023
  • - Research Institution

Excellent biostatistical support, clear and actionable insights.

The biostatistical support provided was top-notch, offering clear and actionable insights that were critical to the success of our study. The team was responsive and worked closely with us to ensure the analysis met our specific needs.

Mr. Peter Padberg I profile

Mr. Peter Padberg I

🇺🇸 United States

9.4

    Reviewed:

  • - Health Technology Assessment
  • - 10 weeks September - November 2023
  • - Pharmaceutical Company

Thorough and insightful health technology assessment.

The health technology assessment was thorough and provided valuable insights that were critical to our decision-making process. The team demonstrated a deep understanding of the health economics involved and delivered a well-rounded analysis.

Dr. Madeline Kessler profile

Dr. Madeline Kessler

🇲🇽 Mexico

9.1

    Reviewed:

  • - Clinical Data Management
  • - 6 weeks June - July 2023
  • - CRO

Timely and accurate data management, great collaboration.

The data management services were delivered on time and with great accuracy. Collaboration with the team was smooth, and they were always available to address any concerns or questions we had. We were very satisfied with the outcome.

Frederick Fay profile

Frederick Fay

🇷🇺 Russia

9.2

    Reviewed:

  • - Data Visualization
  • - 3 weeks December 2023
  • - Pharmaceutical Company

Highly effective data visualization, easy to interpret and impactful.

The data visualization services were highly effective, making complex data easy to interpret and communicate. The visualizations were impactful and played a crucial role in our stakeholder presentations.

Gregory Lowe-Rohan profile

Gregory Lowe-Rohan

🇪🇸 Spain

6.3

    Reviewed:

  • - Stability Studies
  • - 16 months July 2023 - November 2024
  • - Pharmaceutical Company

Stability studies lacked detail, required additional validation.

The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.

Olive Satterfield Jr. profile

Olive Satterfield Jr.

🇫🇷 France

9.3

    Reviewed:

  • - Project Management
  • - 10 weeks July - September 2023
  • - Biotech Company

Seamless project management, results exceeded expectations.

Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.

Dr. Jordan Labadie profile

Dr. Jordan Labadie

🇷🇺 Russia

5.4

    Reviewed:

  • - Process Development
  • - 14 weeks June - September 2024
  • - Biotech Company

Process development project faced delays, communication issues.

The process development project encountered multiple delays, and communication was inconsistent. We had to extend our project timeline due to the setbacks, and this impacted our overall production schedule. The team was capable but seemed overextended.